Landscapes / Companies
Laboratoires Thea not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
6
in active trials · 12 in all
Trials
7 active
18 since 2021
Drugs6
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Articainenot checked |
— |
On the market | Dec 2027Phase 4 trial completes | ||
| Next date | Dec 2027 · Phase 4 trial completes | ||||
| Open drug page | |||||
— |
Phase 3 | Nov 2027Phase 3 trial completes | |||
| Next date | Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Leber Congenital Amaurosis 10, Blindness and 10 more | ||||
| Open drug page | |||||
— |
Phase 2 | 21 Jan 2027Phase 2 trial completes | |||
| Next date | 21 Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Moderate to Severe Vernal Keratoconjunctivitis | ||||
| Open drug page | |||||
— |
Phase 2 | Nov 2027Phase 2 trial completes | |||
| Next date | Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Myopia | ||||
| Open drug page | |||||
— |
Phase 2 | Jul 2028Phase 2 trial completes | |||
| Next date | Jul 2028 · Phase 2 trial completes | ||||
| Also tested for | Retinitis Pigmentosa (RP), Usher Syndrome Type 2 and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Glaucoma, Ocular Hypertension | ||||
| Open drug page | |||||
About
- No active trial
- 6 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021